ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 83 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $445 | +290.4% | 350 | 0.0% | 0.00% | – |
Q2 2023 | $114 | -24.5% | 350 | 0.0% | 0.00% | – |
Q1 2023 | $151 | -18.8% | 350 | 0.0% | 0.00% | – |
Q4 2022 | $186 | – | 350 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -99.9% | 350 | 0.0% | 0.00% | – |
Q1 2021 | $1,628,000 | +162700.0% | 350 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -33.3% | 350 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $3,000 | -40.0% | 350 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $5,000 | +150.0% | 350 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $2,000 | – | 350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |